XKRX
096760
Market cap211mUSD
Oct 08, Last price
4,105.00KRW
1D
-2.96%
1Q
5.12%
Jan 2017
-53.77%
IPO
18.06%
Name
JW Holdings Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
JW Holdings Corporation, alongside its numerous subsidiaries, is a key player in the manufacturing and commercialization of pharmaceuticals and medical devices. Its operations span South Korea and global markets. The company's diverse offerings include ethical medications, non-prescription consumer health goods, and specialized equipment for IV solutions. Established in 1945, JW Holdings maintains its headquarters in Seoul, South Korea.
Key people
Honorary Chairman · since 2021
Co-Chief Executive Officer, Director · since 2021
Ji Wu Choi
Chief Financial Officer · since 2021
Suk Hui Nah
Managing Director
Wu Cheong Chi
Senior Assistant Managing Director
Dong Hyeok Lee
Assistant Managing Director
Se Chan Lee
Senior Assistant Managing Director
Min Ohn
Senior Assistant Managing Director
Gwi Eung Song
Senior Assistant Managing Director
Co-Chief Executive Officer, Director · since 2021
Seon Jae Lee
Non-Executive Independent Director · since 2024
Gu Taek Oh
Non-Executive Independent Director · since 2017
Seong Wu Park
Non-Executive Independent Director
Chan Yeop Yum
Non-Executive Independent Director
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||